Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats

Psychopharmacology

Volumn 161, Issue 2, 2002, Pages 168-179

  Nelson, Christopher L ^a   Burk, Joshua A ^a   Bruno, John P ^a   Sarter, Martin ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acetylcholine release; Attention; Ketamine; Prefrontal cortex; Schizophrenia

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE DERIVATIVE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; ATTENTION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG POTENCY; INSTRUMENTAL CONDITIONING; MALE; MICRODIALYSIS; NONHUMAN; PERFORMANCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSITIZATION; STIMULATION; SYMPTOMATOLOGY;

ACETYLCHOLINE; ANIMALS; ATTENTION; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; KETAMINE; MALE; PREFRONTAL CORTEX; RATS; RATS, INBRED BN; RATS, INBRED F344;

EID: 0036254625     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1004-7     Document Type: Article

References (58)

1. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers
2. Appendix II: Design and optimization of dose regimens: Pharmacokinetic data
3. The schizophrenia ketamine challenge study debate
4. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: A study of Brodmann's areas 8, 9, 10 and 46 and the effects of neuroleptic drug treatment
5. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later
6. Effects of repeated administration of amphetamine on behavioral vigilance: Evidence for 'sensitized' attentional impairments
7. Clinical and sensorimotor gating effects of ketamine in normals
8. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias
9. Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain
10. Detection of basal acetylcholine in rat brain microdialysate
11. Ketamine - Can chronic use impair memory?
12. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
13. Reduced prefrontal cortical dopamine, but not acetylcholine, release after repeated, intermittent phencyclidine administration to rats
14. Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor
15. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
16. Effects of ketamine and pentobarbitone on acetylcholine release from the rat frontal cortex in vivo
17. Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and α2-adrenergic agonists
18. Subanesthetic effects of the noncompetitive NMDA receptor antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
19. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists
20. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
21. Ketamine activates psychosis and alters limbic blood flow in schizophrenia
22. NMDA-sensitive glutamate antagonism: A human model for psychosis
23. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat
24. The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies
25. Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies
26. Dopaminergic mechanisms in idiopathic and drug-induced psychoses
27. Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity
28. Differential effects of single and repeated ketamine administration on dopamine, serotonin, and GABA transmission in rat medial prefrontal cortex
29. Effects of acute D-amphetamine and ketamine on the performance of rats in a serial negative patterning procedure
30. NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers
31. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
32. Behavioral vigilance in rats: Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands
33. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: Selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density
34. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum
35. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
36. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine
37. Repeated pre-treatment with amphetamine sensitizes increases in cortical acetylcholine release
38. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis
39. Glutamate receptor dysfunction and schizophrenia
40. The effects of a sub-anaesthetic dose of ketamine on human selective attention
41. Acetylcholine and hallucinations: Disease-related compared to drug-induced alterations in human consciousness
42. Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection
43. Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats
44. Tolerance to the discriminative stimulus and reinforcing effects of ketamine
45. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: A retrospective study
46. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: Two sides of the same coin?
47. Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis
48. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders
49. Cortical cholinergic inputs mediating arousal, attentional processing, and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents
50. Psychotogenic properties of benzodiazepine receptor inverse agonists
51. Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: Implications for a sensitization model of psychosis in humans
52. The cholinergic system in schizophrenia reconsidered
53. 11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis
54. Bidirectional modulation of basal forebrain N-methyl-D-aspartate receptor function differentially affects visual attention but not visual discrimination performance
55. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects
56. Differential effect of ketamine on the reference and working memory versions of the Morris water maze task